Mark E. Nelson

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Alternate Stoichiometries of α4β2 Nicotinic Acetylcholine Receptors

Mark E. Nelson, Alexander Kuryatov, Catherine H. Choi et al. · Molecular Pharmacology · 2003 · 413 citations

Life Sciences, Biochemistry, Molecular Biology +16

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K. Siggins et al. · Science Immunology · 2021 · 259 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Mutation Causing Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Alters Ca²⁺Permeability, Conductance, and Gating of Human α4β2 Nicotinic Acetylcholine Receptors

Alexander Kuryatov, Volodymyr Gerzanich, Mark E. Nelson et al. · Journal of Neuroscience · 1997 · 232 citations

Life Sciences, Neurobiology, Neuroscience +17

Chronic Nicotine Treatment Up-regulates Human α3β2 but Not α3β4 Acetylcholine Receptors Stably Transfected in Human Embryonic Kidney Cells

Fan Wang, Mark E. Nelson, Alexander Kuryatov et al. · Journal of Biological Chemistry · 1998 · 184 citations · Full text

Medicine, Neuroscience, Pharmacology +17